It was found that an increase in PR3-ANCA has the strongest association with relapses of AAV in patients who: experience a severe relapse, have severe disease manifestations caused by capillaritis such as diffuse alveolar hemorrhage or renal involvement, and in patients treated with rituximab. The gene discussed is PRTN3; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.